Pricing Log in Create free account
Friday 6 November 2026 Export MEDP’s income statement to Excel — free account

Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Medpace Holdings, Inc. (MEDP) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Medpace Holdings, Inc. (MEDP) trades at a EV/EBITDA of 27.0×. Over the past ten years it has ranged from 0.0× (September 2016) to 35.7× (December 2021); the current reading is higher than 78% of that period. That is above the Diagnostics & Research industry median of 23.4× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 28.1× 37.50%
FY2024 20.4× (19.83%)
FY2023 25.5× 12.42%
FY2022 22.7× (32.84%)
FY2021 33.7× 31.93%
FY2020 25.6× 30.55%
FY2019 19.6× 31.45%
FY2018 14.9× (7.99%)
FY2017 16.2× 27.66%
FY2016 12.7× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 26.6× 11.69%
Jun 2026 23.8× 7.10%
Mar 2026 22.2× (20.98%)
Dec 2025 28.1× 5.25%
40 more quarters

Against its own ten years

Low 0.0× High 35.7×
Ten-year median 21.4×
Current reading's percentile 78

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.2×
LH Labcorp Holdings Inc. compare 15.6×
QGEN QIAGEN N.V. compare 17.4×
ICLR ICON PLC compare 17.9×
RVTY Revvity Inc. compare 25.1×
ILMN Illumina, Inc. compare 26.4×
MEDP Medpace Holdings, Inc. 27.0×
CRL Charles River Laboratories International, Inc. compare 31.2×
Diagnostics & Research industry median 23.4×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MEDP